The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 2

More JCP Articles

JCP
Posttrauma Benzodiazepine Use and Subsequent PTSD
Original Research

June 22, 2026

In this naturalistic setting of mass trauma, short-term benzodiazepine use during 30 days postexposure was not associated with increased PTSD risk at 12 months.
, ,
JCP
Predictive Modeling of Suicidal Ideation in US Veterans: PHQ-2 Versus Complex Machine Learning Approaches
Original Research

June 17, 2026

Machine learning models provided a statistically significant, yet clinically modest, performance improvement over the PHQ-2 sum score.
, , , et al
JCP
Race, Ethnicity, Socioeconomic Status, Clinical Characteristics, and Postpartum Depression in Patients with a History of Depressive Episodes
Original Research

June 17, 2026

Patients who were non-White and had lower incomes had higher PPD risk. Higher antidepressant dosing before pregnancy, stopping antidepressants during pregnancy, and moderate-severe symptoms early in pregnancy were associated…
, , , et al
JCP
The Art of Deprescribing: A Framework for Ending Medication with Joseph Goldberg, MD
Podcast

June 16, 2026

Dr. Joseph Goldberg discusses the ASCP deprescribing framework: when to stop medications, managing discontinuation, polypharmacy, and pregnancy considerations.
,
JCP
Gestational Exposure to Sterol Biosynthesis Disrupting Drugs and Risk of Autism Spectrum Disorder
Clinical and Practical Psychopharmacology

June 15, 2026

Dr Andrade discusses a recent study of sterol biosynthesis disrupting drugs and argues that inadequate research methods disallow clinical application of the results.
JCP
Risk Factors for PTSD in a Diverse Cohort of Trauma-Exposed Youth: A 2-Year Longitudinal Study
Original Research

June 15, 2026

PTSD at the initial evaluation and at a 1-month follow-up strongly predicted later PTSD in trauma-exposed youth.
, , , et al
JCP
Hallucinogen–Psychosis Associations Are Confounded by Baseline Psychiatric History
Original Research ▶ Video

June 10, 2026

Apparent associations between hallucinogen use and psychosis appear largely attributable to baseline psychiatric comorbidities rather than direct causal effects.
, , , et al
JCP
County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay
Original Research ▶ Video

June 8, 2026

Across all examined payers, Medicaid funded a disproportionate share—over 50%—of SUD service expenditures.
, , , et al
JCP
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
Original Research

June 3, 2026

Mebufotenin (GH001) demonstrated rapid and significant improvements in depressive symptoms and remission of postpartum depression.
, , , et al
JCP
Forty Years at the PTSD Frontier with Barbara O. Rothbaum, PhD
Podcast

June 2, 2026

Barbara O. Rothbaum, PhD, on PTSD treatment: prolonged exposure, MDMA-assisted therapy with PE, VR exposure therapy, and why SSRIs fall short.
,
JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
Brief Report

June 1, 2026

High fill rates of GLP-1 receptor agonist prescriptions in those with mood disorders could indicate that multimorbidity begets more treatment.
, , , et al
JCP
Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms
Original Research

May 27, 2026

Viloxazine ER was well tolerated and associated with improvements in ADHD, depression, and anxiety symptoms in this real-world study.
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe